Physician profile
Thanh J Van
NPI 1548252430
$5,001.58
in general payments reported to CMS, 2019-2025
22 companies · $1,012 in 2025
The $1,012 reported for 2025 was more than what 83% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.57 · 2020: $182 · 2021: $1,693 · 2022: $809 · 2023: $526 · 2024: $731 · 2025: $1,012.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,863 · Education: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,862.87 |
| Education | $406.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Palette Life Sciences, INC. | $2,346.87 | 2020-2022 | |
| Astellas Pharma US INC | $617.43 | 2020-2025 | Xtandi, Padcev |
| Boston Scientific Corporation | $338.81 | 2022-2025 | Spaceoar Vue System - 10ml |
| Myriad Genetic Laboratories, INC. | $335.07 | 2023-2024 | Prolaris |
| Pfizer INC. | $177.31 | 2025 | |
| Tempus Ai, INC | $160.79 | 2024-2025 | Xt Cdx |
| Teleflex LLC | $139.78 | 2024 | |
| Telix Pharmaceuticals | $135.79 | 2025 | Illuccix |
| Axonics, INC. | $132.21 | 2024 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $125.90 | 2025 | |
| Progenics Pharmaceuticals, INC. | $102.49 | 2023-2025 | Pylarify |
| Abbvie INC. | $92.22 | 2020-2024 | Lupron Depot |
| Janssen Biotech, INC. | $88.53 | 2022 | |
| Procept Biorobotics Corporation | $61.37 | 2024 | Aquabeam System |
| Merck Sharp & Dohme LLC | $32.60 | 2023 | Keytruda |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $20.90 | 2019 | |
| Sumitomo Pharma America, INC. | $19.34 | 2023 | Orgovyx |
| Astrazeneca Pharmaceuticals LP | $19.05 | 2020 | |
| Innovation Technologies INC | $14.59 | 2025 | Irrisept |
| Dendreon Pharmaceuticals LLC | $14.43 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.24 | 2019 | |
| Coloplast Corp | $12.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thanh Van listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.